Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the pancreas. It is characterized by the presence of malignant small cells.
Biomarker and diagnostic research for pancreatic small cell neuroendocrine carcinoma has been reported in the published literature.
No clinical trials have been registered for pancreatic small cell neuroendocrine carcinoma.
202 publications have been identified in PubMed for pancreatic small cell neuroendocrine carcinoma. Kisho has analyzed 137 by research type. Research spans Basic Science / Preclinical (37%), Review / Meta-Analysis (22%), and Gene Therapy / Novel Therapeutics (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 51 | 37% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 8:43 PM UTC
Research summaries |
30 |
22% |
New treatment approaches | 27 | 20% |
Clinical study results | 12 | 9% |
Testing and diagnosis research | 10 | 7% |
Disease patterns and progression | 3 | 2% |
Other research | 2 | 1% |
Patient case studies | 2 | 1% |
Ismail U (2026). [PMID: 36943973](https://pubmed.ncbi.nlm.nih.gov/36943973/). *Unknown Journal*. [Basic Science / Preclinical]
Arends MJ (2026). [PMID: 41724188](https://pubmed.ncbi.nlm.nih.gov/41724188/). *Histopathology*. [Review / Meta-Analysis]
Mehta MP (2026). [PMID: 41033612](https://pubmed.ncbi.nlm.nih.gov/41033612/). *Int J Radiat Oncol Biol Phys*. [Clinical Trial Publication]
Park W (2026). [PMID: 41879829](https://pubmed.ncbi.nlm.nih.gov/41879829/). *N Engl J Med*. [Clinical Trial Publication]
Xie L (2026). [PMID: 41557983](https://pubmed.ncbi.nlm.nih.gov/41557983/). *Cancer Discov*. [Clinical Trial Publication]
Zhou H (2026). [PMID: 41803498](https://pubmed.ncbi.nlm.nih.gov/41803498/). *Nat Microbiol*. [Basic Science / Preclinical]
Pokora B (2026). [PMID: 41957000](https://pubmed.ncbi.nlm.nih.gov/41957000/). *Expert Opin Pharmacother*. [Review / Meta-Analysis]
Köse H (2026). [PMID: 41143762](https://pubmed.ncbi.nlm.nih.gov/41143762/). *Gastroenterology*. [Basic Science / Preclinical]
Wang Z (2026). [PMID: 41061171](https://pubmed.ncbi.nlm.nih.gov/41061171/). *Annu Rev Pathol*. [Review / Meta-Analysis]
Willner J (2026). [PMID: 41489019](https://pubmed.ncbi.nlm.nih.gov/41489019/). *Histopathology*. [Diagnostic / Biomarker]